Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μL versus 20,000/μL

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1143-1149

  Heckman, K D ^a   Weiner, G J ^a   Davis, C S ^a   Strauss, R G ^a   Jones, M P ^a   Burns, C P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ADULT; AGED; APHERESIS; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

EID: 0031049727     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1143     Document Type: Article

References (14)

1. Gaydos LA, Freireich EJ, Mantel N: The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Eng J Med 266:905-909, 1962
2. Higby DJ, Cohen E, Holland JF, et al: The prophylactic treatment of thrombocytopenic leukemic patients with platelets: A double blind study. Transfusion 14:440-446, 1974
3. Slichter SJ, Harker LA: Thrombocytopenia: Mechanisms and management of defects in platelet production. Clin Haematol 7:523-539, 1978
4. Gmür J, Burger J, Schanz U, et al: Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 338:1223-1226, 1991
5. Platelet transfusion therapy. JAMA 257:1777-1780, 1987
6. Beutler E: Platelet transfusions: The 20,000/μL trigger. Blood 81:1411-1413, 1993
7. Mayer RJ, Davis RB, Schiffer CA, et al: Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903, 1994
8. Herzig RH, Wolff SN, Lazarus HM, et al: High-dose cytosine arabinoside therapy for refractory leukemia. Blood 62:361-369, 1983
9. Paciucci PA, Davis RB, Holland JF, et al: Mitoxantrone and constant infusion etopside for relapsed and refractory acute myelocytic leukemia. Am J Clin Oncol 13:516-519, 1990
10. Ajani JA, Welch SR, Raber MN, et al: Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 8:141-153, 1990
11. Landis JR, Heyman ER, Koch GG: Average partial association in three-way contingency tables: A review and discussion of alternative tests. Int Stat Rev 46:237-254, 1978
12. SAS Institute: SAS/STAT Guide for Personal Computers, Version 6 Edition. Cary, NC, SAS Institute Inc, 1987
13. Dodd RY: Viral contamination of blood components and approaches for reduction of infectivity. Immunol Invest 24:25-28, 1995
14. Dodd RY: Transfusion transmitted HIV. Vox Sang 70:1-3, 1996 (suppl 3)